Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, GermanyDepartment of Medicine III, Faculty of Medicine, Klinikum Rechts der Isar, Technical University Munich, Munich, GermanyA. L. Illert, S. Laßmann, M. Werner, M. Boerries, J. Duyster & R. Thimme
Division of Translational Medical Oncology, German Cancer Research Center and National Center for Tumor Diseases , Heidelberg, GermanyDepartment of Internal Medicine III, University Hospital of Ulm, Ulm, GermanyInstitute for Surgical Pathology, Medical Center, University of Freiburg, Freiburg, GermanyInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, GermanyInstitute for Bioinformatics and Medical Informatics , University of Tübingen,...
Department of Oncology, Hematology, Stem Cell Transplantation, Cell- and Immunotherapies, Clinical Immunology and Rheumatology, University Hospital Bonn, Bonn, GermanyDepartment of Translational Medical Oncology, National Center for Tumor Diseases , Dresden, GermanyDepartment of Dermatology, University Duisburg-Essen, University Hospital Essen, Essen, GermanyDepartment of Medicine A: Hematology, Oncology, and Pneumology, University Hospital Münster , Münster, GermanyUniversity Cancer...
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Researchers and regulators plan for a future without lab animals - Nature MedicineThe US Food and Drug Administration has reduced requirements for preclinical animal testing, leading to a surge of interest in organoids, tissue chips and in silico testing.
Source: NatureMedicine - 🏆 451. / 53 Read more »
Research software engineering accelerates the translation of biomedical research for health - Nature MedicineResearch software engineering accelerates the translation of biomedical research for health. Comment from Dave_Horsfall Muzz_Haniffa and colleagues sangerinstitute
Source: NatureMedicine - 🏆 451. / 53 Read more »
Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results - Nature MedicineIn patients with DNA damage response-deficient solid tumors, the oral ATR kinase inhibitor camonsertib was well tolerated; a recommended phase 2 dose was identified; and encouraging anti-tumor activity was observed, with the highest response rate observed in patients with ovarian cancer.
Source: NatureMedicine - 🏆 451. / 53 Read more »
Republicans should not help Bernie Sanders push socialized medicineThe Senate Committee on Health, Education, Labor and Pensions held a hearing last week about high prices for prescription drugs — specifically, insulin.
Source: WashTimes - 🏆 235. / 63 Read more »
AI should be regulated like medicine and nuclear power: UK ministerU.K. Labour Party politician Lucy Powell said licenses and regulations similar to the nuclear industry should apply to those developing AI, as the chair of the government's R&D agency repeated warnings of the threat posed by the technology. Powell also believes such advanced technology could greatly impact the U.K. economy and the Labour Party is purportedly finishing up its own policies on AI and related technologies.
Source: Cointelegraph - 🏆 562. / 51 Read more »
The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatment - Nature MedicineAnalysis of tumor samples from patients with nasopharyngeal carcinoma shows that gemcitabine plus cisplatin chemotherapy activates a unique population of innate-like B cells, which enhance the cytotoxic CD8+ T cell response and are associated with better clinical outcomes.
Source: NatureMedicine - 🏆 451. / 53 Read more »